Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +45.22%
#3 Glidr Glidr +45.16%
#4 Cysic Cysic +25.83%
#5 Tutorial Tutorial +24.70%
#6 Walrus Walrus +24.17%
#7 Humanity Humanity +17.87%
#8 Enso Enso +17.09%
#9 Codatta Codatta +14.69%
#10 Huma Finance Huma Finance +14.16%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
ViewRay, Inc. ViewRay, Inc.

ViewRay, Inc.

VRAY
Peringkat dalam Saham #37058
ViewRay, Inc. specializes in the development, production, and global... ViewRay, Inc. specializes in the development, production, and global distribution of advanced radiation therapy systems that leverage magnetic resonance imaging (MRI). These integrated systems are utilized to both image and deliver treatment for cancer patients in various countries, including the United States, France, Taiwan, and the United Kingdom. The company's key product, MRIdian, is an MRI-guided radiation therapy solution engineered to address critical concerns during treatment, such as beam distortion and potential skin toxicity. ViewRay's client base spans a diverse range of medical facilities, including university research and teaching hospitals, local community hospitals, private medical practices, government institutions, and independent cancer treatment centers. MRIdian systems are sold to these clients via ViewRay's direct sales force and through its established distribution channels. The company was founded in 2004 and operates out of its main office in Oakwood, Ohio.
Harga Saham
$0.014
Terakhir disinkronkan: 2023-08-21
Kapitalisasi Pasar
$2.07M
Perubahan (1 hari)
-1.41%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan ViewRay, Inc. (VRAY)

Kategori

Healthcare
Pendapatan untuk ViewRay, Inc. (VRAY)
Pendapatan pada Aug 2026 TTM: 0
Menurut laporan keuangan terbaru dari ViewRay, Inc., pendapatan saat ini (TTM) adalah 0. Pada tahun 2026, perusahaan menghasilkan pendapatan sebesar 0 sama dengan pendapatan pada tahun 2026 yang sebesar 0. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan ViewRay, Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US